Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eloisa Arbustini is active.

Publication


Featured researches published by Eloisa Arbustini.


Cardiovascular Research | 2018

Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F. Leite-Moreira; Thomas Thum; Carlo G. Tocchetti; Gilda Varricchi; Jolanda van der Velden; Roddy Walsh; Stephane Heymans

Dilated cardiomyopathy (DCM) frequently affects relatively young, economically, and socially active adults, and is an important cause of heart failure and transplantation. DCM is a complex disease and its pathological architecture encounters many genetic determinants interacting with environmental factors. The old perspective that every pathogenic gene mutation would lead to a diseased heart, is now being replaced by the novel observation that the phenotype depends not only on the penetrance-malignancy of the mutated gene-but also on epigenetics, age, toxic factors, pregnancy, and a diversity of acquired diseases. This review discusses how gene mutations will result in mutation-specific molecular alterations in the heart including increased mitochondrial oxidation (sarcomeric gene e.g. TTN), decreased calcium sensitivity (sarcomeric genes), fibrosis (e.g. LMNA and TTN), or inflammation. Therefore, getting a complete picture of the DCM patient will include genomic data, molecular assessment by preference from cardiac samples, stratification according to co-morbidities, and phenotypic description. Those data will help to better guide the heart failure and anti-arrhythmic treatment, predict response to therapy, develop novel siRNA-based gene silencing for malignant gene mutations, or intervene with mutation-specific altered gene pathways in the heart.This article is part of the Mini Review Series from the Varenna 2017 meeting of the Working Group of Myocardial Function of the European Society of Cardiology.


The Journal of Thoracic and Cardiovascular Surgery | 2017

Simplified mitral valve repair in pediatric patients with connective tissue disorders

Luca A. Vricella; William A. Ravekes; Eloisa Arbustini; Robert D.B. Jaquiss; Constantine Mavroudis; Harry C. Dietz; Marshall L. Jacobs; Narutoshi Hibino; Duke E. Cameron

Background: In pediatric patients with connective tissue disorders (CTDs), early cardiac presentation often involves severe mitral regurgitation (MR) associated with severe bileaflet prolapse and, less frequently, aortic root enlargement. We adopted a simplified repair to address MR and prevent systolic anterior motion (SAM) in this unique group of patients. Materials and Methods: Retrospective review of clinical and echocardiographic data of all pediatric patients (age < 18 years) with CTD and MR undergoing simplified repair at 3 institutions (2000‐2014). Results: Eighteen children who underwent surgery for severe MR and bileaflet prolapse were identified. All were treated with ring annuloplasty and Alfieri edge‐to‐edge repair. Median age and weight were 8.2 years (range, 0.4‐17.2 years) and 24.9 kg (5.6‐63.3 kg), respectively. Median left ventricular end diastolic dimension median z score was 4.9 (2.1‐11.9). One patient died (5.6%), and there were no other major complications. Among survivors, 94.4% had mild regurgitation or less, with no stenosis or SAM at median clinical follow‐up of 2.4 years (range, 0‐13.9 years). Median left ventricular end‐diastolic dimension z score regressed to 1.3 (−0.5 to 4.3). Conclusions: In pediatric patients with CTD and severe MR, a simplified approach is associated with intermediate‐term competence, absence of SAM or significant stenosis, and regression of left ventricular enlargement.


Journal of The European Academy of Dermatology and Venereology | 2016

Involvement of dermal microvascular basement membrane in senile purpura: quantitative immunohistochemical study

Riccardo Borroni; Sara Grassi; Monica Concardi; Manuela Agozzino; Clelia Caspani; Calogero Giordano; M Vignini; Eloisa Arbustini

A. Lallas,* P.R. Chellini, M.G. Guimar~ aes, N. Cordeiro, Z. Apalla, C. Longo, E. Moscarella, R. Alfano, G. Argenziano Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy, Instituto de Dermatologia Professor Rubem David Azulay, Santa Casa da Miseric ordia do Rio de Janeiro, Rio de Janeiro, Brazil, First Department of Dermatology, Aristotle University, Thessaloniki, Greece, Department of Anesthesiology, Surgery and Emergency, Second University of Naples, Naples, Italy, Dermatology Unit, Second University of Naples, Naples, Italy *Correspondence: A. Lallas. E-mail: [email protected]


Journal of the American College of Cardiology | 2016

Left Ventricular Noncompaction : A Distinct Genetic Cardiomyopathy?

Eloisa Arbustini; Valentina Favalli; Nupoor Narula; Alessandra Serio; Maurizia Grasso


Journal of the American College of Cardiology | 2016

Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics

Valentina Favalli; Eliana Disabella; Mariadelfina Molinaro; Marilena Tagliani; Anna Scarabotto; Alessandra Serio; Maurizia Grasso; Nupoor Narula; Carmela Giorgianni; Clelia Caspani; Monica Concardi; Manuela Agozzino; Calogero Giordano; Alexandra Smirnova; Takahide Kodama; Lorenzo Giuliani; Elena Rosa Antoniazzi; Riccardo G. Borroni; Camilla Vassallo; Filippo Mangione; Laura Scelsi; Stefano Ghio; Carlo Pellegrini; Marialuisa Zedde; Laura Fancellu; GianPietro Sechi; Antonello Ganau; Stefania Piga; Annarita Colucci; Daniela Concolino


Drug Metabolism and Pharmacokinetics | 2013

Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients.

Mariadelfina Molinaro; Laurent R. Chiarelli; Luigi Biancone; Marco Castagneto; Luigi Boschiero; Francesco Pisani; Massimo Sabbatini; Silvio Sandrini; Eloisa Arbustini; Carmine Tinelli; Mario Regazzi; Francesco Paolo Schena; Giuseppe Paolo Segoloni


Heart | 2016

Genetic causes of dilated cardiomyopathy

Valentina Favalli; Alessandra Serio; Maurizia Grasso; Eloisa Arbustini


Jacc-cardiovascular Imaging | 2018

Targeted Imaging for Cell Death in Cardiovascular Disorders

Aditya Shekhar; Peter S. Heeger; Chris Reutelingsperger; Eloisa Arbustini; Navneet Narula; Leonard Hofstra; Jeroen J. Bax; Jagat Narula


International Journal of Cardiology | 2018

Common presentation of rare diseases: Aortic aneurysms & valves

Eloisa Arbustini; Valentina Favalli; Alessandro Di Toro; Lorenzo Giuliani; Giuseppe Limongelli


Journal of Cardiovascular Electrophysiology | 2017

The post-DANISH era in clinical cardiology: Need of a better selection of patients for implantable cardioverter-defibrillator in dilated cardiomyopathy

Marcello Disertori; Michela Masè; Marta Rigoni; Giandomenico Nollo; Eloisa Arbustini; Flavia Ravelli

Collaboration


Dive into the Eloisa Arbustini's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jagat Narula

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge